Cisplatin-induced inhibition of the calcium-calmodulin complex, neuronal nitric oxide synthase activation and their role in stomach distention

被引:23
作者
Jarve, RK [1 ]
Aggarwal, SK [1 ]
机构
[1] MICHIGAN STATE UNIV,DEPT ZOOL,E LANSING,MI 48824
关键词
neuronal nitric oxide synthase; calcium-calmodulin complex; cisplatin; stomach distention; emesis;
D O I
10.1007/s002800050581
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cisplatin (8 mg/kg; i.p.) treatment of Wistar rats produced no change in nitric oxide synthase (NOS) localization or its intensity for up to 5 days. However, immunohistochemically the levels of L-citrulline and the Ca2+-calmodulin complex were decreased after only 3 days. An in vitro experiment using an analog of calmodulin, Mero-Calmodulin-1, showed that cis-diammine-diaquacisplatinum(II), a hydrolyzed form of cisplatin, inhibited the calmodulin conformational shift from occurring through a direct interaction with the calmodulin molecule. The results indicate that distention of the stomach was due to inhibition of neuronal NOS activation by a direct interaction between cisplatin and the calcium binding sites of the calmodulin molecule.
引用
收藏
页码:341 / 348
页数:8
相关论文
共 41 条
[1]   CISPLATIN-INDUCED PEPTIC-ULCERS, VAGOTOMY, ADRENAL AND CALCIUM MODULATION [J].
AGGARWAL, SK ;
SANANTONIO, JD ;
SOKHANSANJ, A ;
MILLER, C .
ANTI-CANCER DRUGS, 1994, 5 (02) :177-193
[2]   A HISTOCHEMICAL APPROACH TO THE MECHANISM OF ACTION OF CISPLATIN AND ITS ANALOGS [J].
AGGARWAL, SK .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1993, 41 (07) :1053-1073
[3]  
AGGARWAL SK, 1980, CANCER CHEMOTH PHARM, V4, P249
[4]   CISPLATIN AND CARBOPLATIN INDUCED CHANGES IN THE NEUROHYPOPHYSIS AND PARATHYROID, AND THEIR ROLE IN NEPHROTOXICITY [J].
AGGARWAL, SK ;
FADOOL, JM .
ANTI-CANCER DRUGS, 1993, 4 (02) :149-162
[5]  
ANDREWS PA, 1990, CANCER CELL-MON REV, V2, P35
[6]   AN ANALYSIS OF FACTORS RESPONSIBLE FOR RESORPTION OF EMBRYOS IN CISPLATIN-TREATED RATS [J].
BAJT, ML ;
AGGARWAL, SK .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1985, 80 (01) :97-107
[8]  
CHAO SH, 1984, MOL PHARMACOL, V26, P75
[9]  
CHOKSI A, 1987, PLATINUM OTHER METAL, P375
[10]  
COBBS CS, 1995, CANCER RES, V55, P727